03 Jul 2020 --- As people and their pets both experience increased obesity rates, bioactive salmon peptides could provide a promising avenue for addressing this phenomenon across genera. This is detailed in Biomega Group’s latest whitepaper, which examines burgeoning research in this area. However, the Norway-based bioscience company flags that collaboration between academic and industrial producers will be crucial to ensuring the future success of peptides as a novel therapeutic and to making a vital contribution to the treatment or prevention of various diseases.
